Bristol-Myers Squibb and Lonza expand manufacturing agreement
Bristol-Myers Squibb and Lonza announced a multi-year expansion of their existing biologics manufacturing agreement. The contract expansion will include production of commercial quantities of a second Bristol-Myers biologic medicine at Lonza’s mammalian manufacturing facility in Portsmouth, NH. October 30, 2014